Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.2.1.23 (
beta-galactosidase
)
14,648
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Sympathetic neurons in the superior cervical ganglion (SCG) of adult rats depend on target-derived
nerve growth factor
(
NGF
) for maintenance of tyrosine hydroxylase (TH) levels and the noradrenergic neurotransmitter system. Axotomy of a SCG results in
NGF
deprivation, causing a decline in TH activity; continuous local application of
NGF
can prevent this decline in TH activity. We now report that injection of a defective herpes simplex virus 1 vector that expresses
NGF
(pHSVngf) into a SCG can prevent the decline in TH activity that follows axotomy. SCG of adult rats were injected with either pHSVngf virus or pNFlac virus, which expresses Escherichia coli
beta-galactosidase
. Analysis of RNA from pHSVngf-infected SCG indicated that the
NGF
gene was efficiently transcribed and processed. Furthermore, 4 days after pHSVngf injection animals underwent axotomy of the virus-injected SCG. After another 10 days, animals were sacrificed and both the injected-axotomized and contralateral control ganglia were assayed for TH activity. Axotomy of SCG injected with pNFlac virus produced a 50% decline in TH activity relative to control ganglia (P = 0.02). In contrast, SCG injected with pHSVngf virus did not show a decline in TH activity following axotomy; instead, these ganglia manifested an 18% increase in TH levels relative to control ganglia. These data demonstrate that herpes simplex virus 1 vectors can be used to modify neuronal physiology in vivo; specifically, expression of a critical gene product by neural cells that do not normally produce it has potential applications for gene therapy.
...
PMID:Expression of nerve growth factor in vivo from a defective herpes simplex virus 1 vector prevents effects of axotomy on sympathetic ganglia. 131 46
A sensitive two-site enzyme immunoassay (EIA) system was established for mouse beta nerve growth factor (
NGF
) isolated from mouse submaxillary gland. Our EIA system is based on the sandwiching of antigen between anti-mouse beta
NGF
antibody IgG coated on a polystyrene plate and biotinylated anti-mouse beta
NGF
antibody IgG. The bound antibody complex was quantified with streptavidin linked-beta-D-galactosidase (beta-D-galactosidase,
EC 3.2.1.23
). With this system
NGF
concentrations as low as 0.02 pg/well (corresponding to 8 x 10(-19) mol) could be measured reproducibly. The sensitivity of this EIA system permitted the quantification of endogenous immunoreactive beta
NGF
in rat serum. The mean level in serum of male rats (153.2 pg/ml) was found to be almost the same as that of female rats (127.6 pg/ml).
...
PMID:Highly sensitive enzyme immunoassay for beta-nerve growth factor (NGF): a tool for measurement of NGF level in rat serum. 209 47
Rat pheochromocytoma PC12 cells have been modified genetically by the use of replication-defective retroviral vectors containing either the bacterial gene for
beta-galactosidase
(lac Z) or cDNAs for mouse beta-nerve growth factor (
NGF
) and the bacterial gene for neomycin resistance. Using the lac Z vector, clonal lines of PC12 cells were obtained in which almost 100% of cells stably expressed this histochemical marker. Infection of PC12 cells or the derived subclone PC12-BAG, which expresses
beta-galactosidase
, with the
NGF
vectors resulted in autocrine differentiation as assessed by extensive neurite formation, which occurred within hours after infection and was maintained for weeks in culture. Neurite formation could be partially blocked by antibodies to
NGF
. The percentage of cells expressing neurite outgrowth was greater than that of PC12 cells treated with exogenous
NGF
. PC12 cells infected with the
NGF
vectors were shown to release this trophic factor into the medium using a two-site enzyme immunoassay and a bioassay on 'naive' PC12 cells. PC12 cells genetically modified using these vectors provide a means to: follow the fate of the cells after transplantation into animals; test for delivery in vivo of
NGF
and catecholamines by grafted, autocrine-differentiated PC12 cells; and study the long-term actions of
NGF
on responsive cells without adding exogenous
NGF
.
...
PMID:Autocrine differentiation of PC12 cells mediated by retroviral vectors. 210 98
A partial cDNA clone [2.4 kilobase (kb)] for the
nerve growth factor
-inducible large external (NILE) glycoprotein was selected from a lambda gt 11 expression library constructed using mRNA from PC 12 cells. A 0.2 kb subclone (pNILE-1B) was used for Northern blot analysis of NILE message present in 2 NILE-positive neuronal cell lines and 2 NILE-negative glial cell lines. pNILE-1B hybridizes with components of 6.8 and 2.0 kb in the 2 neuronal cell lines but fails to show hybridization with any components in the 2 glial cell lines. Only the 6.8 kb species would be large enough to code for the NILE polypeptide. A rabbit antiserum was prepared against the NILE-
beta-galactosidase
fusion protein produced by the NILE clone. This antiserum (anti-NILE-beta-gal) immunoprecipitates NILE glycoprotein from neuronal cell lines, further confirming the authenticity of the NILE cDNA clone. The epitope recognized by anti-NILE-beta-gal is contained in an 85 kDa tryptic fragment from the phosphorylated carboxy terminus of NILE. The 160 kDa tryptic fragment containing the amino terminus is not recognized by anti-NILE-beta-gal. Both immunoprecipitation and immunofluorescence experiments indicate that the anti-NILE-beta-gal epitope is not exposed on the cell surface but is accessible only after cells are treated with detergent. The cytoplasmic nature of the determinant is also indicated by its absence on a truncated, soluble form of NILE released from cells (possibly by a proteolytic mechanism) into the medium.(ABSTRACT TRUNCATED AT 250 WORDS)
...
PMID:Characterization of a partial cDNA clone for the NILE glycoprotein and identification of the encoded polypeptide domain. 246 66
The complete mouse prepro-
nerve growth factor
(
NGF
) DNA was fused to the carboxyl terminus of the
beta-galactosidase
(lac-z) gene of Escherichia coli. Similarly, a genomic fragment encoding the human
NGF
comprising codons 11 to 106 (from a total of 118) was fused to the fifth codon of the amino terminus of
beta-galactosidase
. Both bacterial vectors produce high amounts of the chimeric proteins. After cell lysis most of the chimeric mouse preproNGF protein is insoluble and appears in the pellet, whereas the majority of the chimeric human beta-NGF remains in the supernatant. Purification of the fusion proteins from the soluble fraction was achieved by affinity chromatography to p-aminophenyl beta-D-thio-galactoside Sepharose. Yields of the purified chimeric proteins were increased threefold to fourfold by the addition of protease inhibitors in the lysis and chromatography buffers. Their antigenic similarity to the preproNGF and mouse beta-NGF was examined by their interaction to sera raised against synthetic peptides which reproduce sequences of the precursor protein and to sera directed against native and denatured mouse beta-NGF using enzyme-linked immunoabsorbent assay (ELISA) techniques. Antibodies to the peptide N2 (-163 to -139) interacted with high affinity with the chimeric mouse preproNGF protein. Antisera to native and denatured mouse beta-NGF interacted with both chimeric proteins but with a variable degree of affinity. These results provide direct evidence that certain antisera to mouse beta-NGF can cross-react with the human beta-NGF molecule.
...
PMID:Synthesis of chimeric mouse nerve growth factor precursor and human beta-nerve growth factor in Escherichia coli: immunological properties. 264 14
A partial cDNA clone [2.4 kilobase (kb)] for the
nerve growth factor
-inducible large external (NILE) glycoprotein was selected from a lambda gt11 expression library constructed using mRNA from PC 12 cells. A 0.2 kb subclone (pNILE-1B) was used for Northern blot analysis of NILE message present in 2 NILE-positive neuronal cell lines and 2 NILE-negative glial cell lines. pNILE-1B hybridizes with components of 6.8 and 2.0 kb in the 2 neuronal cell lines but fails to show hybridization with any components in the 2 glial cell lines. Only the 6.8 kb species would be large enough to code for the NILE polypeptide. A rabbit antiserum was prepared against the NILE-
beta-galactosidase
fusion protein produced by the NILE clone. This antiserum (anti-NILE-beta-gal) immunoprecipitates NILE glycoprotein from neuronal cell lines, further confirming the authenticity of the NILE cDNA clone. The epitope recognized by anti-NILE-beta-gal is contained in an 85 kDa tryptic fragment from the phosphorylated carboxy terminus of NILE. The 160 kDa tryptic fragment containing the amino terminus is not recognized by anti-NILE-beta-gal. Both immunoprecipitation and immunofluorescence experiments indicate that the anti-NILE-beta-gal epitope is not exposed on the cell surface but is accessible only after cells are treated with detergent. The cytoplasmic nature of the determinant is also indicated by its absence on a truncated, soluble form of NILE released from cells (possibly by a proteolytic mechanism) into the medium. This released NILE is 15-20 kDa smaller than the detergent-extracted NILE and, in addition to lacking the anti-NILE-beta-gal epitope, does not contain the cytoplasmic site(s) of phosphorylation. Nucleotide sequencing of the pNILE-1B subclone confirms the location of the anti-NILE-beta-gal epitope in the cytoplasmic domain. The clone contains an open reading frame coding for a 79 amino acid segment of the polypeptide that differs in only 2 residues from the cytoplasmic domain of the L1 glycoprotein.
...
PMID:Characterization of a partial cDNA clone for the NILE glycoprotein and identification of the encoded polypeptide domain. 272 51
A comparison was made between three different strategies for measuring beta-nerve growth factor (
NGF
) by fluorometric enzyme immunoassay. The substrate used was 4-methylumbelliferyl-beta-galactoside and the enzyme reaction was followed in a Microfluor plate reader (Dynatech). After optimizing incubation times, concentrations, buffers, pH, and washings, a primary anti-
NGF
antibody directly conjugated to
beta-galactosidase
gave the best detection limit (2 X 10(-17) M) of purified mouse
NGF
(Mr 26,000) in a two-site sandwich assay. Biotinylated secondary antibodies followed by streptavidin conjugated
beta-galactosidase
proved to be 200-fold less sensitive in a similar assay. Finally, blotting
NGF
onto nitrocellulose membranes for detection with the same biotin-streptavidin steps after incubation with unlabelled primary antibodies resulted in a detection limit of 3 X 10(-12) M. All three methods indicated the same level (4 X 10(-11) M) of endogenous
NGF
in the rat brain hippocampus.
...
PMID:Highly sensitive enzyme immunoassays for beta-nerve growth factor. 310 12
Rat clonal pheochromocytoma PC12h cells were found to bind
beta-galactosidase
modified with specific glycosides. The enzyme modified with p-aminophenyl beta-D-glucoside was most effectively bound to the cells, followed by alpha-D-mannoside and alpha-D-glucoside. The binding was dependent on the number of PC12h cells, the incubation interval, and the pH; the maximal binding at 4 degrees C was obtained by incubation with 75 micrograms of cell protein for 15 min at pH 4.0. The binding proved to be a saturable and receptor-mediated process, and the apparent Km value and the maximal binding capacity of the cells with beta-D-glucosylated
beta-galactosidase
were 1.03 +/- 0.06 microM and 333 +/- 24 pmol/min/mg of protein, respectively. When the cells were cultured in the presence of
nerve growth factor
(
NGF
), GM1, GM2, and a ganglioside mixture, marked morphological differentiation was observed in the presence of
NGF
, and the specificity of the binding was also affected. By supplementation of
NGF
in the culture medium, the cells lost the selectivity of the glycoside binding, whereas cells cultured with GM1 supplement showed increased binding of the specific glycosides.
...
PMID:Specific binding of glycosylated beta-galactosidase to rat clonal pheochromocytoma PC12h cells: effects of nerve growth factor and gangliosides. 312 66
Endo-
beta-galactosidase
treatment of glycopeptides derived from the trypsinate and membranes of PC12 pheochromocytoma cells and cultured sympathetic neurons demonstrated the presence of poly(N-acetyllactosaminyl) units on tri- and tetraantennary oligosaccharides, some of which have a core fucose residue and a 2,6-substituted alpha-linked mannose residue. Nerve growth factor induced differentiation of the PC12 cells led to a small but significant decrease in the proportion of these oligosaccharides. Poly(N-acetyllactosaminyl) oligosaccharides were also identified in a major 230 000-Da cell-surface glycoprotein (the
nerve growth factor
inducible large external, or NILE, glycoprotein) of PC12 cells and appear to account for much or all of the difference in size between this glycoprotein as compared to the immunochemically cross-reactive 205 000-Da species present in postnatal brain. Glycoproteins containing poly(N-acetyllactosaminyl) oligosaccharides were selectively labeled by treatment of PC12 cells with endo-beta-galactosidase to expose N-acetylglucosamine residues, followed by incubation with galactosyltransferase and UDP-[14C]galactose. Sodium dodecyl sulfate-polyacrylamide gel electrophoresis and fluorography revealed the presence of a number of distinct PC12 cell glycoproteins that contain these oligosaccharides and have apparent molecular weights in the range of 25 000-250 000. Treatment of PC12 cells with
nerve growth factor
(
NGF
) altered the relative labeling of several of the glycoprotein bands, with a time course similar to the effects of
NGF
on neurite outgrowth.(ABSTRACT TRUNCATED AT 250 WORDS)
...
PMID:Poly(N-acetyllactosaminyl) oligosaccharides in glycoproteins of PC12 pheochromocytoma cells and sympathetic neurons. 375 58
A sensitive two-site enzyme immunoassay system for mouse beta nerve growth factor (
NGF
) was developed, based on the sandwiching of the antigen between anti-mouse beta
NGF
antibody IgG coated to a polystyrene tube and anti-mouse beta
NGF
antibody Fab'-linked beta-D-galactosidase (beta-D-galactoside hydrolase,
EC 3.2.1.23
). This method has the following advantages: (a) the procedures are simple and rapid compared to bioassay or two-site radioimmunoassay; (b) antibody Fab'-beta-D-galactosidase complex is more stable than 125I-labeled antibody; (c) purified beta
NGF
is detectable at a concentration as low as 10 pg/ml. Our enzyme immunoassay was used to examine the levels of
NGF
in some tissues of mice. The submaxillary gland contained a high concentration of
NGF
. However, other tissues, such as the heart, brain, and skeletal muscle, and serum did not contain detectable
NGF
. These results support recent findings by other investigators that
NGF
was not found in the organs/tissues other than the submaxillary gland of mice.
...
PMID:A highly sensitive enzyme immunoassay for mouse beta nerve growth factor. 640 64
1
2
3
4
Next >>